Many neurotransmitters and growth factors produce intracellular second messengers through the polyphosphoinositide cycle. Through diacylglycerol activation of protein kinase C, neuronal cell division and differentiation is controlled. The diacylglycerol stimulus is removed either by phosphorylation using diacylglycerol kinase or by the hydrolytic production of additional second messengers using diacylglycerol lipase and monoacylglycerol lipase. The second messenger profile is dependent on the regulation of diacylglycerol lipase, a glycoprotein present in neuronal plasma and nuclear membranes with a localization resembling protein kinase C. The long term goal is to understand the regulation of these lipases, the cause of their very high activities in Alzheimer membranes, and their role in neuronal degeneration. Bradykinin causes receptor-mediated 4-fold increased activities of these lipases in primary neuronal-enriched cell cultures. The generality and mechanism of this stimulation will be determined. Bradykinin and other neurotransmitters linked with protein kinase C activation will be tested for acylhydrolase (diacylglycerol lipase, monoacylglycerol lipase, and phospholipase A2) stimulation in primary neuronal and glial cultures. The most likely mechanism for stimulation is phosphorylation of the lipases or of an endogenous protein inhibitor by protein kinase. This will be tested with intact cells and with purified enzymes. The exact location of the phosphate on diacylglycerol lipase will be determined using our sequence information and antibodies. Synthesis of new enzyme will be evaluated with diacylglycerol lipase antibodies. Known inhibitors of diacylglycerol lipase, C-MT peptide, RHC-80267, and R-59022, will be used with intact and permeabilized cells to determine if basal and stimulated activities of diacylglycerol lipase can be inhibited. Activities of mono- and diacylglycerol lipase and phospholipase A2 will be determined in skin fibroblasts from Alzheimer's disease (AD) patients. If increased activities are observed, then experiments will be devised to explain the activation on the basis of receptor stimulation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS029441-02
Application #
3416263
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1991-04-01
Project End
1994-03-31
Budget Start
1992-04-01
Budget End
1993-03-31
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
Schools of Medicine
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Antony, Pierre; Freysz, Louis; Horrocks, Lloyd A et al. (2003) Ca2+-independent phospholipases A2 and production of arachidonic acid in nuclei of LA-N-1 cell cultures: a specific receptor activation mediated with retinoic acid. Brain Res Mol Brain Res 115:187-95
Antony, P; Freysz, L; Horrocks, L A et al. (2001) Effect of retinoic acid on the Ca2+-independent phospholipase A2 in nuclei of LA-N-1 neuroblastoma cells. Neurochem Res 26:83-8
Antony, P; Farooqui, A A; Horrocks, L A et al. (2001) Effect of D609 on phosphatidylcholine metabolism in the nuclei of LA-N-1 neuroblastoma cells: a key role for diacylglycerol. FEBS Lett 509:115-8
Farooqui, A A; Litsky, M L; Farooqui, T et al. (1999) Inhibitors of intracellular phospholipase A2 activity: their neurochemical effects and therapeutical importance for neurological disorders. Brain Res Bull 49:139-53
Farooqui, A A; Horrocks, L A (1999) Purification of lipases and phospholipases by heparin-sepharose chromatography. Methods Mol Biol 109:133-43
Farooqui, A A; Yang, H C; Hirashima, Y et al. (1999) Determination of plasmalogen-selective phospholipase A2 activity by radiochemical and fluorometric assay procedures. Methods Mol Biol 109:39-47
Ong, W Y; Horrocks, L A; Farooqui, A A (1999) Immunocytochemical localization of cPLA2 in rat and monkey spinal cord. J Mol Neurosci 12:123-30
Farooqui, A A; Horrocks, L A (1998) Plasmalogen-selective phospholipase A2 and its involvement in Alzheimer's disease. Biochem Soc Trans 26:243-6
Sandhya, T L; Ong, W Y; Horrocks, L A et al. (1998) A light and electron microscopic study of cytoplasmic phospholipase A2 and cyclooxygenase-2 in the hippocampus after kainate lesions. Brain Res 788:223-31
Farooqui, A A; Yang, H C; Rosenberger, T A et al. (1997) Phospholipase A2 and its role in brain tissue. J Neurochem 69:889-901

Showing the most recent 10 out of 31 publications